Belviq: A guide to the first FDA-approved obesity drug in 13 years

The Food and Drug Administration tries to shrink America's bulging waistlines by greenlighting a new medication that helps overweight people feel full faster

A new diet drug, Belviq, has been approved by the FDA for obese people and overweight people with a body mass index of 27 or more who have at least one weight-related health condition.
(Image credit: Jose Luis Pelaez, Inc./Blend Images/Corbis)

For the first time in more than a decade, the Food and Drug Administration has approved an anti-obesity drug: Belviq, a new appetite-suppressing pill, was cleared earlier this week (even though the feds initially rejected the drug in 2010 due to safety concerns). Here's what you need to know:

How does it work?

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us